NEWS
May 25, 2011
Watson Buys Generic Drug Developer for $562 Million
Watson Pharmaceuticals Inc has acquired privately held generic drug developer Specifar Pharmaceuticals SA for $562 million in cash, expanding its global footprint...
|
|
|
|
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.
|
|